Huvitz Co. Ltd Market Cap ($45.48 Million)
Market Cap & Net Worth: Huvitz Co. Ltd (065510)
Huvitz Co. Ltd market cap. Huvitz Co. Ltd (KQ:065510) has a market capitalization of $45.48 Million (₩67.12 Billion) as of November 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22074 globally and #1378 in its home market, demonstrating a -4.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Huvitz Co. Ltd's stock price ₩6170.00 by its total outstanding shares 10877895 (10.88 Million). Also see Huvitz Co. Ltd (065510) cash conversion ratio for how efficiently the company converts equity into cash flow.
Huvitz Co. Ltd Market Cap History (2015–2026)
Huvitz Co. Ltd market cap history from 2015 to 2026. Data shows change from $100.44 Million to $45.48 Million (-7.81% CAGR). Check today's stock price for Huvitz Co. Ltd for real-time trading data and today's change.
Index Memberships
Huvitz Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$207.23 Billion | 0.02% | #655 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$207.23 Billion | 0.02% | #655 of 1384 |
Weight: Huvitz Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Huvitz Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Huvitz Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 065510 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Huvitz Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Huvitz Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $100.44 Million | $69.65 Billion | $6.53 Billion | 0.00x | 0.02x |
| 2016 | $89.68 Million | $66.92 Billion | $11.07 Billion | 0.00x | 0.01x |
| 2017 | $88.73 Million | $70.39 Billion | $3.11 Billion | 0.00x | 0.03x |
| 2018 | $54.53 Million | $78.86 Billion | $7.09 Billion | 0.00x | 0.01x |
| 2019 | $57.48 Million | $87.99 Billion | $7.87 Billion | 0.00x | 0.01x |
| 2020 | $52.12 Million | $70.09 Billion | -$2.72 Billion | 0.00x | N/A |
| 2021 | $63.98 Million | $95.02 Billion | $8.99 Billion | 0.00x | 0.01x |
| 2022 | $74.75 Million | $109.42 Billion | $17.08 Billion | 0.00x | 0.00x |
| 2023 | $140.43 Million | $117.74 Billion | $9.98 Billion | 0.00x | 0.01x |
| 2024 | $60.01 Million | $117.88 Billion | $8.71 Billion | 0.00x | 0.01x |
Competitor Companies of 065510 by Market Capitalization
Companies near Huvitz Co. Ltd in the global market cap rankings as of November 5, 2026. Also see total assets of Huvitz Co. Ltd for a full breakdown of the balance sheet.
Key companies related to Huvitz Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Huvitz Co. Ltd (2015–2026)
Market capitalization of Huvitz Co. Ltd from 2015 to today. Between 2015 and today, Huvitz Co. Ltd's market cap moved from $100.44 Million to $ 45.48 Million, with a yearly change of -7.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩45.48 Million | -32.64% |
| 2025 | ₩67.53 Million | +12.53% |
| 2024 | ₩60.01 Million | -57.27% |
| 2023 | ₩140.43 Million | +87.87% |
| 2022 | ₩74.75 Million | +16.84% |
| 2021 | ₩63.98 Million | +22.76% |
| 2020 | ₩52.12 Million | -9.32% |
| 2019 | ₩57.48 Million | +5.41% |
| 2018 | ₩54.53 Million | -38.55% |
| 2017 | ₩88.73 Million | -1.06% |
| 2016 | ₩89.68 Million | -10.71% |
| 2015 | ₩100.44 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Huvitz Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.48 Million USD |
| MoneyControl | $45.48 Million USD |
| MarketWatch | $45.48 Million USD |
| marketcap.company | $45.48 Million USD |
| Reuters | $45.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Huvitz Co. Ltd
Huvitz Co., Ltd. develops and sells optometric medical equipment worldwide. The company offers ophthalmic and optical equipment comprising refractive equipment, such as auto ref-keratometers, auto lensmeters, digital refractors, chart projectors, and unit tables; and diagnostic equipment comprising slit lamps, non-contact tonometers, and applanation tonometers, as well as ophthalmologic diagnosti… Read more